Noncirrhotic portal hypertension after arsenic ingestion.
Five years after arsenic therapy, the patient described had noncirrhotic portal hypertension, for which he had splenectomy and anastomosis of the splenic vein to the left renal vein. During the 12-year postoperative period he had Bowen's disease (skin carcinoma), but has had normal liver function and no further gastrointestinal bleeding. Arsenic exposure in humans is common throughout the world and may lead to late complications such as noncirrhotic portal hypertension and skin carcinoma, as well as malignancies of the lungs, liver, and lymphatic systems. It may also lead to severe arteriosclerosis with involvement of the heart and extremities.
D001151:Arsenic / Q000009:adverse effects*; D001913:Bowen's Disease / Q000139:chemically induced; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000139:chemically induced
D001151:Arsenic